Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
Department of Cardiology, West Vicenza Hospitals, Arzignano, Italy.
Eur Stroke J. 2023 Dec;8(4):915-922. doi: 10.1177/23969873231190432. Epub 2023 Jul 25.
Data regarding the risk of ischemic stroke within 1 year after the post-acute phase of COVID-19 remain scant. We assess the risk of ischemic stroke in COVID-19 survivors after SARS-CoV-2 infection by performing a systematic review and meta-analysis of the available data.
Following the PRISMA guidelines, we searched Medline and Scopus to locate all articles published up to February 11, 2023, reporting the risk of incident ischemic stroke in adult patients recovered from COVID-19 infection compared to non-infected patients (controls) defined as those who did not experience the infection over the same follow-up period. Ischemic stroke risk was evaluated using the Mantel-Haenszel random effects models with adjusted Hazard ratio (HR) as the effect measure with 95% confidence interval (CI) while heterogeneity was assessed using Higgins statistic.
Overall, 23,559,428 patients (mean age 56, 1 year, 54.3% males), of whom 1,595,984 had COVID-19, were included. Over a mean follow-up of 9.2 months, ischemic stroke occurred in 4.40 [95% CI: 4.36-4.43] out of 1000 patients survived to COVID-19 compared to 3.25 [95% CI:3.21-3.29] out of 1000 controls. Recovered COVID-19 patients presented a higher risk of ischemic stroke ((HR: 2.06, 95% CI: 1.75-2.41, < 0.0001, = 63.7%) compared to people who did not have COVID-19. COVID-19 patients hospitalized at the time of the infection have a subsequent higher risk of stroke during the follow-up compared to those non-hospitalized.
Recovered COVID-19 patients have a higher risk of ischemic stroke compared to subjects from the general population within 9 months from the index infection.
关于 COVID-19 急性后期后 1 年内发生缺血性卒中的风险的数据仍然很少。我们通过对现有数据进行系统回顾和荟萃分析,评估 COVID-19 幸存者在 SARS-CoV-2 感染后的缺血性卒中风险。
根据 PRISMA 指南,我们检索了 Medline 和 Scopus,以查找截至 2023 年 2 月 11 日发表的所有文章,这些文章报告了与未感染 COVID-19 的患者(对照组)相比,从 COVID-19 感染中康复的成年患者发生缺血性卒中的风险。对照组定义为在相同的随访期间未发生感染的患者。使用调整后的危害比(HR)作为效应量,采用 Mantel-Haenszel 随机效应模型评估缺血性卒中风险,95%置信区间(CI),同时使用 Higgins 统计量评估异质性。
共有 23559428 名患者(平均年龄 56 岁,1 年,54.3%为男性),其中 1595984 名患有 COVID-19。在平均 9.2 个月的随访中,与对照组 1000 名患者中有 3.25 名(95%CI:3.21-3.29)相比,1000 名 COVID-19 存活患者中有 4.40 名(95%CI:4.36-4.43)发生缺血性卒中。与未感染 COVID-19 的患者相比,康复的 COVID-19 患者发生缺血性卒中的风险更高(HR:2.06,95%CI:1.75-2.41, < 0.0001, = 63.7%)。感染时住院的 COVID-19 患者在随访期间发生卒中的风险高于未住院的患者。
与一般人群相比,COVID-19 康复患者在感染后 9 个月内发生缺血性卒中的风险更高。